collagenase clostridium histolyticum-aaes (Qwo)
collagenase clostridium histolyticum-aaes is an FDA-licensed reference biologic from Endo Global Aesthetics Limited. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2020
Reference approved
Reference product
Qwo collagenase clostridium histolyticum-aaes
Endo Global Aesthetics Limited
- Approved
- Jul 06, 2020
- Marketing
- Disc
- Center
- CDER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for collagenase clostridium histolyticum-aaes, in chronological order.
Reference approval
Approval date of the reference collagenase clostridium histolyticum-aaes product.
6 yr ago
Frequently asked questions
Are there biosimilars approved for collagenase clostridium histolyticum-aaes (Qwo)?
No 351(k) biosimilars or interchangeable biosimilars referencing collagenase clostridium histolyticum-aaes are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.